ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Herceptin With Chemo Increases Survival In Early-Stage Breast Cancer, Study Finds

December 30, 2005

In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970

June 1, 1975

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

In Brief: Hong, Posner Awarded ACS Research Professorships; Hawaii Wins Center Grants

July 26, 1996

NCI Advisory Group Meetings for July

June 27, 1975

8 Pittsburg Employees Started Coalition That Lasted 8 Days

June 10, 1994